FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine, namely applying a composition of glycine and phenazepam, in psychoneurology, and having therapeutic action on physiological and functional activity of the nervous system in various borderline and pathological conditions of the nervous activity while being safe for application. The combinations in the oral dispersible form having therapeutic action on activating and inhibitory functions of the nervous system contain bromdihydrochlorphenylbenzodiazepine, glycine (aminoacetic acid) and pyridoxine, as well as acceptable excipients.
EFFECT: combinations provide the fast onset of the therapeutic effect and reduced and/or relieved side effects, particularly CNS depression.
7 cl, 4 ex, 5 tbl
